Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

PURPOSE: Adjuvant therapy for intermediate-risk and high-risk localized prostate cancer decreases the number of deaths from this disease. Surrogates for overall survival (OS) could expedite the evaluation of new adjuvant therapies. METHODS: By June 2013, 102 completed or ongoing randomized trials we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Xie, Wanling, Regan, Meredith M., Buyse, Marc, Halabi, Susan, Kantoff, Philip W., Sartor, Oliver, Soule, Howard, Clarke, Noel W., Collette, Laurence, Dignam, James J., Fizazi, Karim, Paruleker, Wendy R., Sandler, Howard M., Sydes, Matthew R., Tombal, Bertrand, Williams, Scott G., Sweeney, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652387/
https://ncbi.nlm.nih.gov/pubmed/28796587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.9987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados